
Basil Systems
Basil leverages AI/ML to dramatically speed access to the vital insights that drive medical product development success.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
* | $11.5m | Early VC | |
Total Funding | 000k |
USD | 2023 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Basil Systems operates in the healthcare sector, leveraging advanced AI and Machine Learning technologies to provide a powerful SaaS platform that accelerates access to critical insights. This platform is designed to enhance data-driven decision-making processes, ultimately driving product development success and improving patient outcomes. Basil Systems serves leading healthcare enterprises, including pharmaceutical companies and life sciences organizations, by unlocking intelligence buried in multiple disconnected data sources. The company’s business model revolves around offering a subscription-based SaaS platform, which generates revenue through recurring subscription fees. Additionally, Basil Systems provides technology solutions for internal data integration, ensuring scalability and peak performance as data volumes and transactional demands increase. The company’s mission is to drive transformative change in the pharmaceutical industry, enhancing operational efficiency and commercial success while optimizing health outcomes.
Keywords: AI, Machine Learning, SaaS, healthcare, pharmaceutical, data integration, patient outcomes, decision-making, big data, life sciences.